Hepatic encephalopathy epidemiology and demographics

Jump to navigation Jump to search

Hepatic encephalopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatic Encephalopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatic encephalopathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatic encephalopathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatic encephalopathy epidemiology and demographics

CDC on Hepatic encephalopathy epidemiology and demographics

Hepatic encephalopathy epidemiology and demographics in the news

Blogs on Hepatic encephalopathy epidemiology and demographics

Directions to Hospitals Treating Hepatic encephalopathy

Risk calculators and risk factors for Hepatic encephalopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

The prevalence of subclinical hepatic encephalopathy estimated to be 62,000 cases per 100,000 in patients with hepatic cirrhosis. The survival probability of hepatic encephalopathy is approximately 42% at 1 year and 23% at 3 years in follow-up. Chronic liver disease and cirrhosis which are the main causes of hepatic encephalopathy, affect more than 5.5 million people in the United States and hundreds of millions all over the world.

Epidemiology and Demographics

Incidence

  • The incidence of hepatic encephalopathy is unknown.
  • The prevalence of subclinical hepatic encephalopathy estimated to be 62,000 cases per 100,000 in patients with hepatic cirrhosis.[1]

Case-fatality rate/Mortality rate

The survival probability of hepatic encephalopathy is approximately 42% at 1 year and 23% at 3 years in follow-up.[2]

Age

  • The incidence of hepatic encephalopathy increases with aging.

Gender

  • Men are more commonly affected by hepatic encephalopathy than women.

Region

Chronic liver disease and cirrhosis which are the main causes of hepatic encephalopathy, affect more than 5.5 million people in the United States and hundreds of millions all over the world.[3]

References

  1. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR (2001). "Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis". J Gastroenterol Hepatol. 16 (5): 531–5. PMID 11350549.
  2. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V; et al. (1999). "Prognostic significance of hepatic encephalopathy in patients with cirrhosis". J Hepatol. 30 (5): 890–5. PMID 10365817.
  3. Bleibel W, Al-Osaimi AM (2012). "Hepatic encephalopathy". Saudi J Gastroenterol. 18 (5): 301–9. doi:10.4103/1319-3767.101123. PMC 3500018. PMID 23006457.

Template:WH Template:WS